INDOL(SULFONIL)-N-HYDROXYBENZAMIDE DERIVATIVES AS SELECTIVE HDAC INHIBITORS Russian patent published in 2021 - IPC C07D209/40 C07D409/04 

Abstract RU 2748835 C1

FIELD: chemistry.

SUBSTANCE: invention relates to compounds of sulfonylhydroxamic acid of a general formula I which can be used as selective inhibitors of histone deacetylases (HDAC). In the general formula I, the ring A constitutes phenyl, naphthalenyl and benzothiophenyl; the ring B constitutes phenyl; R1 constitutes alkyl; R2, R3 constitute hydrogen, alkoxy, halogen, nitro, benzyloxy, phenyl, CF3; R4, R5, R6 constitute hydrogen; X=O. The invention also relates to a method of synthesis of the described compounds and use thereof as selective HDAC inhibitors.

EFFECT: achieved is synthesis of compound which can be used as selective HDAC inhibitor.

15 cl, 3 dwg, 3 tbl, 18 ex

Similar patents RU2748835C1

Title Year Author Number
TREATMENT METHOD 2012
  • Bassil Anna K.
  • Bejnke Seren
  • Prindzhkha Rabinder Kumar
RU2621148C2
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS 2018
  • Vadivelu, Saravanan
  • Rajagopal, Sridharan
  • Burri, Raghunadha Reddy
  • Garapaty, Shivani
  • Sivanandhan, Dhanalakshmi
  • Thakur, Manish Kumar
  • Natarajan, Tamizharasan
  • Swamy, Indu N
  • Nagaraju, Nagendra
  • Kanagaraj, Subramaniam
  • Mohd, Zainuddin
  • Sarkar, Sayantani
  • Samanta, Swapan Kumar
  • Hariprakash
RU2797822C2
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS 2016
  • Dzhons Elison
  • Kemp Mark
  • Stokli Martin
  • Gibson Karl
  • Uitlok Gevin
RU2717238C2
METHOD OF OBTAINING HYDROXAMIC ACIDS, DERIVATIVES OF 2-ARYL-2.3-DIHYDROQUINAZOLIN-4(1H)-ONES 2020
  • Khachatryan Derenik Sarkisovich
  • Balaev Aleksandr Nikolaevich
  • Okhmanovich Kirill Anatolevich
  • Kolotaev Anton Vladimirovich
  • Matevosyan Karine Rafaelovna
  • Osipov Vasilij Nikolaevich
RU2744750C1
2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3,5]NONANE DERIVATIVES AND USE THEREOF AS GHRELIN RECEPTOR ANTAGONISTS OR INVERSE AGONISTS 2011
  • Bkhattachar'Ja Samit Kumar
  • Kehmeron Kimberli O'Kif
  • Fernando Dilini Prasadini
  • Kan Dehniel Vej-Shun
  • Londregan Ehllin Timoti
  • Makkljur Kim Frehnsis
  • Simila Suvi Tuula Mar'Jukka
RU2524341C2
THIAZOLPYRIMIDINES 2012
  • Germann Jokhannes Kornelius
  • Louri, Dzh. Li Edvin
  • Lukas Metyu S.
  • Lyuk Kin-Chun Tomas
  • Pedilla Fernando
  • Vanner Yutta
  • Se Venvej
  • Chzhan Syaokhu
RU2610840C2
ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS 2015
  • Gerner Seitzberg Jimmi
  • Titilola Akinleminu Kronborg Tine
  • Poljak Visnja
  • Friberg Gitte
  • Teuber Lene
RU2743074C2
NOVEL 4-AMINO-N-HYDROXYBENZAMIDES AS HDAC INHIBITORS FOR TREATING CANCER 2012
  • Lin Syanfen
  • Tsyu Tszunsin
  • Tan Gochzhi
  • Von Dzhejson Kristofer
  • Chzhan Chzhenshan
RU2591190C2
MODULATORS OF NUCLEAR RECEPTORS 2016
  • Argiriadi, Maria, A.
  • Breinlinger, Eric, C.
  • Cusack, Kevin, P.
  • Hobson, Adrian, D.
  • Potin, Dominique
  • Barth, Martine
  • Amaudrut, Jerome
  • Poupardin, Olivia
  • Mounier, Laurent
  • Kort, Michael, E.
RU2715897C2
AROMATIC 6,7-DISUBSTITUTED 3-QUINOLINECARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF (VARIANTS), PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USE THEREOF IN DRUG MANUFACTURING 2002
  • Larsson Joakim
  • She Peter
RU2281940C2

RU 2 748 835 C1

Authors

Srivari, Chandrasekhar

Mainkar, Prathama Satyendra

Reddy, Chada Raji

Kotamraju, Srigiridhar

Togapur, Pavan Kumar

Muppidi, Subbarao Mohan Venkata

Sharma, Somesh

Jha, Ashok Kumar

Arumugam, Prem Kumar

Dates

2021-05-31Published

2018-08-06Filed